{"transactions":[{"id":673763,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-27T20:00:46.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":35.69,"value":53535.0,"ownership":{"direct":true},"balance_after":27638,"source":{"system":"sec-edgar","filing":"0002014440-26-000012","document":"wk-form4_1787860844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000012/wk-form4_1787860844.xml","form_type":"4"}},{"id":695684,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-05T20:52:07.000Z","date":"2026-08-05","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":36.28,"value":54420.0,"ownership":{"direct":true},"balance_after":26138,"source":{"system":"sec-edgar","filing":"0002014440-26-000010","document":"wk-form4_1785963124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000010/wk-form4_1785963124.xml","form_type":"4"}},{"id":710707,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-13T20:31:42.000Z","date":"2026-07-10","kind":"sale","planned":true,"acquired":false,"shares":18586,"price":41.14,"value":764628.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."}],"balance_after":209337,"source":{"system":"sec-edgar","filing":"0002014639-26-000011","document":"wk-form4_1783974699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000011/wk-form4_1783974699.xml","form_type":"4"}},{"id":729126,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2026-06-23T21:24:25.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":false,"shares":1266903,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 100% with respect to the performance stock units granted to the Reporting Person on May 13, 2025. As a result, 1,266,903 shares vested on June 22, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 100% with respect to the performance stock units granted to the Reporting Person on May 13, 2025. As a result, 1,266,903 shares vested on June 22, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1266903},"source":{"system":"sec-edgar","filing":"0001443841-26-000007","document":"wk-form4_1782249862.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000144384126000007/wk-form4_1782249862.xml","form_type":"4"}},{"id":729125,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-23T21:24:25.000Z","date":"2026-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":612549,"price":38.32,"value":23472877.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld to satisfy tax withholding obligations associated with the vesting of performance stock units on June 22, 2026."}],"balance_after":790330,"source":{"system":"sec-edgar","filing":"0001443841-26-000007","document":"wk-form4_1782249862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000144384126000007/wk-form4_1782249862.xml","form_type":"4"}},{"id":729124,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-23T21:24:25.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":true,"shares":1266903,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 100% with respect to the performance stock units granted to the Reporting Person on May 13, 2025. As a result, 1,266,903 shares vested on June 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1402879,"source":{"system":"sec-edgar","filing":"0001443841-26-000007","document":"wk-form4_1782249862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000144384126000007/wk-form4_1782249862.xml","form_type":"4"}},{"id":740239,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-06-12T20:10:12.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":18586,"price":38.06,"value":707383.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."}],"balance_after":227923,"source":{"system":"sec-edgar","filing":"0002014639-26-000009","document":"wk-form4_1781295005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000009/wk-form4_1781295005.xml","form_type":"4"}},{"id":743084,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-10T10:04:27.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":36000,"price":37.7,"value":1357200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026."}],"balance_after":284751,"source":{"system":"sec-edgar","filing":"0002014866-26-000011","document":"wk-form4_1781085864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000011/wk-form4_1781085864.xml","form_type":"4"}},{"id":779127,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47338,"kind":"person","name":"Thompson Juliet","position":1,"cik":"0001715258","reported_name":"Thompson Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:12:07.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":6518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":12973,"source":{"system":"sec-edgar","filing":"0001715258-26-000007","document":"wk-form4_1778789524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000171525826000007/wk-form4_1778789524.xml","form_type":"4"}},{"id":779126,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47338,"kind":"person","name":"Thompson Juliet","position":1,"cik":"0001715258","reported_name":"Thompson Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:12:07.000Z","date":"2026-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1117,"price":38.28,"value":42758.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares used to satisfy tax withholding obligations associated with the vesting of Restricted Stock Units on May 12, 2026."}],"balance_after":6455,"source":{"system":"sec-edgar","filing":"0001715258-26-000007","document":"wk-form4_1778789524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000171525826000007/wk-form4_1778789524.xml","form_type":"4"}},{"id":779128,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47339,"kind":"person","name":"Humphreys Keith","position":1,"cik":"0002014900","reported_name":"Humphreys Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:11:13.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":6518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":16042,"source":{"system":"sec-edgar","filing":"0002014900-26-000009","document":"wk-form4_1778789470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201490026000009/wk-form4_1778789470.xml","form_type":"4"}},{"id":779125,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47337,"kind":"person","name":"Kingsley Stuart A","position":1,"cik":"0001369067","reported_name":"Kingsley Stuart A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:10:43.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":6518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":12100,"source":{"system":"sec-edgar","filing":"0001369067-26-000009","document":"wk-form4_1778789440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000136906726000009/wk-form4_1778789440.xml","form_type":"4"}},{"id":779124,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":32061,"kind":"person","name":"NINIVAGGI DANIEL A","position":1,"cik":"0001257599","reported_name":"NINIVAGGI DANIEL A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:10:01.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":6518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":27163,"source":{"system":"sec-edgar","filing":"0001257599-26-000008","document":"wk-form4_1778789399.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000125759926000008/wk-form4_1778789399.xml","form_type":"4"}},{"id":779123,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:07:55.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":6518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":12242,"source":{"system":"sec-edgar","filing":"0001827169-26-000013","document":"wk-form4_1778789272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000182716926000013/wk-form4_1778789272.xml","form_type":"4"}},{"id":779122,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47336,"kind":"person","name":"Stejbach Mark","position":1,"cik":"0001487937","reported_name":"Stejbach Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:07:13.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":6518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":27087,"source":{"system":"sec-edgar","filing":"0001487937-26-000009","document":"wk-form4_1778789230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000148793726000009/wk-form4_1778789230.xml","form_type":"4"}},{"id":779120,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":29981,"kind":"person","name":"Wheadon David E.","position":1,"cik":"0001789507","reported_name":"Wheadon David E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:06:15.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":10430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":30780,"source":{"system":"sec-edgar","filing":"0001789507-26-000008","document":"wk-form4_1778789170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000178950726000008/wk-form4_1778789170.xml","form_type":"4"}},{"id":837858,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:32:18.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":6302,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (RSUs) convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (RSUs) convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 14, 2024, the reporting person was granted 6,302 RSUs in accordance with the Indivior Group Deferred Bonus Plan 2018. Those RSUs vested in a single installment on March 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 14, 2024, the reporting person was granted 6,302 RSUs in accordance with the Indivior Group Deferred Bonus Plan 2018. Those RSUs vested in a single installment on March 14, 2026."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-03-14","underlying":"Common Stock","underlying_shares":6302},"source":{"system":"sec-edgar","filing":"0002014866-26-000008","document":"wk-form4_1773779535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000008/wk-form4_1773779535.xml","form_type":"4"}},{"id":837857,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:32:18.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2843,"price":31.11,"value":88445.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares used to satisfy tax withholding obligations associated with the vesting of RSUs on March 14, 2026."}],"balance_after":320751,"source":{"system":"sec-edgar","filing":"0002014866-26-000008","document":"wk-form4_1773779535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000008/wk-form4_1773779535.xml","form_type":"4"}},{"id":837856,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:32:18.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":6302,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (RSUs) convert into shares of the Issuer's common stock on a one-for-one basis."}],"balance_after":323594,"source":{"system":"sec-edgar","filing":"0002014866-26-000008","document":"wk-form4_1773779535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000008/wk-form4_1773779535.xml","form_type":"4"}},{"id":843883,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-13T20:25:33.000Z","date":"2026-03-13","kind":"purchase","planned":false,"acquired":true,"shares":8,"price":31.085,"value":248.68,"ownership":{"direct":true},"balance_after":5724,"source":{"system":"sec-edgar","filing":"0001827169-26-000010","document":"wk-form4_1773433529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000182716926000010/wk-form4_1773433529.xml","form_type":"4"}},{"id":848644,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47337,"kind":"person","name":"Kingsley Stuart A","position":1,"cik":"0001369067","reported_name":"Kingsley Stuart A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T13:54:36.000Z","date":"2026-03-06","kind":"purchase","planned":false,"acquired":true,"shares":940,"price":31.865,"value":29953.1,"ownership":{"direct":true},"balance_after":5582,"source":{"system":"sec-edgar","filing":"0001369067-26-000006","document":"wk-form4_1773237273.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000136906726000006/wk-form4_1773237273.xml","form_type":"4"}},{"id":848640,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-11T12:12:31.000Z","date":"2026-03-09","kind":"purchase","planned":false,"acquired":true,"shares":31,"price":32.56,"value":1009.36,"ownership":{"direct":true},"balance_after":5716,"source":{"system":"sec-edgar","filing":"0001827169-26-000008","document":"wk-form4_1773231148.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000182716926000008/wk-form4_1773231148.xml","form_type":"4"}},{"id":858306,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":5946,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This award is fully vested in accordance with its terms, effective March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This award is fully vested in accordance with its terms, effective March 3, 2026."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":5946},"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":858305,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Performance Stock Units","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":23975,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 18,364 shares vested out of the 23,975 target amount."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 18,364 shares vested out of the 23,975 target amount."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":23975},"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":858304,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2682,"price":31.98,"value":85770.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares used to satisfy tax withholding obligations associated with the vesting of restricted stock units on March 3, 2026."}],"balance_after":24638,"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":858303,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":5946,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":27320,"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":858302,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":8283,"price":31.98,"value":264890.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026."}],"balance_after":21374,"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":858301,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:48.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":18364,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 18,364 shares vested out of the 23,975 target amount."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit and restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":29657,"source":{"system":"sec-edgar","filing":"0002014440-26-000007","document":"wk-form4_1772744446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000007/wk-form4_1772744446.xml","form_type":"4"}},{"id":858300,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2026-03-05T21:00:14.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":113510,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2028-03-03","underlying":"Common Stock","underlying_shares":113510},"source":{"system":"sec-edgar","filing":"0002014866-26-000006","document":"wk-form4_1772744411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000006/wk-form4_1772744411.xml","form_type":"4"}},{"id":858299,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:14.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":86949,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":317292,"source":{"system":"sec-edgar","filing":"0002014866-26-000006","document":"wk-form4_1772744411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000006/wk-form4_1772744411.xml","form_type":"4"}},{"id":858298,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:00:14.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":87597,"price":31.98,"value":2801352.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In 2024, 204,904 shares vested in respect of performance stock units granted to the Reporting  Person on March 3, 2021.  These shares were subject to a further two-year holding period. On March 3, 2026, the holding period ended and 87,597 shares were withheld to satisfy tax withholding obligations."}],"balance_after":230343,"source":{"system":"sec-edgar","filing":"0002014866-26-000006","document":"wk-form4_1772744411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000006/wk-form4_1772744411.xml","form_type":"4"}},{"id":858296,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":62542,"kind":"person","name":"Burris Jeffrey W","position":1,"cik":"0001484322","reported_name":"Burris Jeffrey W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Performance Stock Units","published_at":"2026-03-05T20:59:35.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":104300,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting\nPerson on March 3, 2023, of which 79,893 shares vested out of the 104.300 target amount."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting\nPerson on March 3, 2023, of which 79,893 shares vested out of the 104.300 target amount."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":104300},"source":{"system":"sec-edgar","filing":"0001484322-26-000013","document":"wk-form4_1772744373.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000148432226000013/wk-form4_1772744373.xml","form_type":"4"}},{"id":858295,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":62542,"kind":"person","name":"Burris Jeffrey W","position":1,"cik":"0001484322","reported_name":"Burris Jeffrey W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-05T20:59:35.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":36032,"price":31.98,"value":1152303.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026."}],"balance_after":71518,"source":{"system":"sec-edgar","filing":"0001484322-26-000013","document":"wk-form4_1772744373.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000148432226000013/wk-form4_1772744373.xml","form_type":"4"}},{"id":858294,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":62542,"kind":"person","name":"Burris Jeffrey W","position":1,"cik":"0001484322","reported_name":"Burris Jeffrey W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-05T20:59:35.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":79893,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting\nPerson on March 3, 2023, of which 79,893 shares vested out of the 104.300 target amount."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":107550,"source":{"system":"sec-edgar","filing":"0001484322-26-000013","document":"wk-form4_1772744373.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000148432226000013/wk-form4_1772744373.xml","form_type":"4"}},{"id":858956,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Performance Stock Units","published_at":"2026-03-05T20:59:02.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":132565,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting\nPerson on March 3, 2023, of which 101,544 shares vested out of the 132,565 target amount."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting\nPerson on March 3, 2023, of which 101,544 shares vested out of the 132,565 target amount."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":132565},"source":{"system":"sec-edgar","filing":"0002014639-26-000006","document":"wk-form4_1772744339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000006/wk-form4_1772744339.xml","form_type":"4"}},{"id":858955,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-05T20:59:02.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":45797,"price":31.98,"value":1464588.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026."}],"balance_after":246509,"source":{"system":"sec-edgar","filing":"0002014639-26-000006","document":"wk-form4_1772744339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000006/wk-form4_1772744339.xml","form_type":"4"}},{"id":858954,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-05T20:59:02.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":101544,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting\nPerson on March 3, 2023, of which 101,544 shares vested out of the 132,565 target amount."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":292306,"source":{"system":"sec-edgar","filing":"0002014639-26-000006","document":"wk-form4_1772744339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000006/wk-form4_1772744339.xml","form_type":"4"}},{"id":907558,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-12T21:08:22.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":23975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 23,975 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 23,975 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026."}],"balance_after":23975,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":23975},"source":{"system":"sec-edgar","filing":"0002014440-26-000005","document":"wk-form4_1770930497.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000005/wk-form4_1770930497.xml","form_type":"4"}},{"id":907557,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":19081,"kind":"person","name":"Anderson Woodrow D","position":1,"cik":"0002014440","reported_name":"Anderson Woodrow D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:08:22.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":6903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on\nFebruary 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":11293,"source":{"system":"sec-edgar","filing":"0002014440-26-000005","document":"wk-form4_1770930497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201444026000005/wk-form4_1770930497.xml","form_type":"4"}},{"id":907554,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-12T21:07:23.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":113510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 113,510 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026. The shares will then be subject to an additional two-year Holding Period before the vested Shares are released to the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 113,510 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026. The shares will then be subject to an additional two-year Holding Period before the vested Shares are released to the Reporting Person."}],"balance_after":113510,"derivative":{"exercise_price":0,"exercise_date":"2028-03-03","underlying":"Common Stock","underlying_shares":113510},"source":{"system":"sec-edgar","filing":"0002014866-26-000004","document":"wk-form4_1770930440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000004/wk-form4_1770930440.xml","form_type":"4"}},{"id":907553,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":39662,"kind":"person","name":"Preblick Ryan","position":1,"cik":"0002014866","reported_name":"Preblick Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:07:23.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":37358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":317940,"source":{"system":"sec-edgar","filing":"0002014866-26-000004","document":"wk-form4_1770930440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201486626000004/wk-form4_1770930440.xml","form_type":"4"}},{"id":907552,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":62542,"kind":"person","name":"Burris Jeffrey W","position":1,"cik":"0001484322","reported_name":"Burris Jeffrey W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-12T21:05:32.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":104300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 104,300 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 104,300 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026."}],"balance_after":104300,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":104300},"source":{"system":"sec-edgar","filing":"0001484322-26-000011","document":"wk-form4_1770930329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000148432226000011/wk-form4_1770930329.xml","form_type":"4"}},{"id":907551,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":62542,"kind":"person","name":"Burris Jeffrey W","position":1,"cik":"0001484322","reported_name":"Burris Jeffrey W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:05:32.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":26897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":27657,"source":{"system":"sec-edgar","filing":"0001484322-26-000011","document":"wk-form4_1770930329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000148432226000011/wk-form4_1770930329.xml","form_type":"4"}},{"id":907848,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-12T21:04:42.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":132565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 132,565 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 132,565 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026."}],"balance_after":132565,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":132565},"source":{"system":"sec-edgar","filing":"0002014639-26-000004","document":"wk-form4_1770930279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000004/wk-form4_1770930279.xml","form_type":"4"}},{"id":907847,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:04:42.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":33622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":190762,"source":{"system":"sec-edgar","filing":"0002014639-26-000004","document":"wk-form4_1770930279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000004/wk-form4_1770930279.xml","form_type":"4"}},{"id":907550,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":66707,"kind":"person","name":"Barry Patrick A","position":1,"cik":"0001733376","reported_name":"Barry Patrick A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:03:50.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":31380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":31380,"source":{"system":"sec-edgar","filing":"0001733376-26-000004","document":"wk-form4_1770930228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000173337626000004/wk-form4_1770930228.xml","form_type":"4"}},{"id":907548,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":35975,"kind":"person","name":"Ciaffoni Joseph","position":1,"cik":"0001443841","reported_name":"Ciaffoni Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:02:57.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":79976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":135976,"source":{"system":"sec-edgar","filing":"0001443841-26-000004","document":"wk-form4_1770930173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000144384126000004/wk-form4_1770930173.xml","form_type":"4"}},{"id":928947,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47337,"kind":"person","name":"Kingsley Stuart A","position":1,"cik":"0001369067","reported_name":"Kingsley Stuart A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-28T21:11:47.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":3722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":4642,"source":{"system":"sec-edgar","filing":"0001369067-26-000004","document":"wk-form4_1769634705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000136906726000004/wk-form4_1769634705.xml","form_type":"4"}},{"id":928946,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":29981,"kind":"person","name":"Wheadon David E.","position":1,"cik":"0001789507","reported_name":"Wheadon David E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-28T21:10:57.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":5955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":20350,"source":{"system":"sec-edgar","filing":"0001789507-26-000006","document":"wk-form4_1769634652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000178950726000006/wk-form4_1769634652.xml","form_type":"4"}},{"id":928945,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-28T21:10:09.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":3722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":5685,"source":{"system":"sec-edgar","filing":"0001827169-26-000006","document":"wk-form4_1769634606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000182716926000006/wk-form4_1769634606.xml","form_type":"4"}},{"id":928944,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":32061,"kind":"person","name":"NINIVAGGI DANIEL A","position":1,"cik":"0001257599","reported_name":"NINIVAGGI DANIEL A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-28T21:09:01.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":3722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":20645,"source":{"system":"sec-edgar","filing":"0001257599-26-000006","document":"wk-form4_1769634538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000125759926000006/wk-form4_1769634538.xml","form_type":"4"}},{"id":928943,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47336,"kind":"person","name":"Stejbach Mark","position":1,"cik":"0001487937","reported_name":"Stejbach Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-28T21:08:14.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":3722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":20569,"source":{"system":"sec-edgar","filing":"0001487937-26-000006","document":"wk-form4_1769634491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000148793726000006/wk-form4_1769634491.xml","form_type":"4"}},{"id":928942,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47338,"kind":"person","name":"Thompson Juliet","position":1,"cik":"0001715258","reported_name":"Thompson Juliet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-28T21:07:22.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":3722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":7572,"source":{"system":"sec-edgar","filing":"0001715258-26-000004","document":"wk-form4_1769634439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000171525826000004/wk-form4_1769634439.xml","form_type":"4"}},{"id":928941,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47339,"kind":"person","name":"Humphreys Keith","position":1,"cik":"0002014900","reported_name":"Humphreys Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-28T21:05:54.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":3722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the day immediately preceding the date of the first annual meeting of the Issuer's stockholders following the date of grant, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":9524,"source":{"system":"sec-edgar","filing":"0002014900-26-000006","document":"wk-form4_1769634350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201490026000006/wk-form4_1769634350.xml","form_type":"4"}},{"id":944434,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":57,"kind":"person","name":"Ryan Barbara","position":1,"cik":"0001827169","reported_name":"Ryan Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-07T18:51:48.000Z","date":"2026-01-05","kind":"purchase","planned":true,"acquired":true,"shares":775,"price":35.3926,"value":27429.265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash."}],"balance_after":1963,"source":{"system":"sec-edgar","filing":"0001827169-26-000004","document":"wk-form4_1767811905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000182716926000004/wk-form4_1767811905.xml","form_type":"4"}},{"id":944435,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47339,"kind":"person","name":"Humphreys Keith","position":1,"cik":"0002014900","reported_name":"Humphreys Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-07T18:50:38.000Z","date":"2026-01-05","kind":"purchase","planned":true,"acquired":true,"shares":775,"price":35.3926,"value":27429.265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash."}],"balance_after":5802,"source":{"system":"sec-edgar","filing":"0002014900-26-000004","document":"wk-form4_1767811835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000201490026000004/wk-form4_1767811835.xml","form_type":"4"}},{"id":944433,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":32061,"kind":"person","name":"NINIVAGGI DANIEL A","position":1,"cik":"0001257599","reported_name":"NINIVAGGI DANIEL A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-07T18:49:33.000Z","date":"2026-01-05","kind":"purchase","planned":true,"acquired":true,"shares":775,"price":35.3926,"value":27429.265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash."}],"balance_after":16923,"source":{"system":"sec-edgar","filing":"0001257599-26-000004","document":"wk-form4_1767811770.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000125759926000004/wk-form4_1767811770.xml","form_type":"4"}},{"id":944432,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":47336,"kind":"person","name":"Stejbach Mark","position":1,"cik":"0001487937","reported_name":"Stejbach Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-07T18:48:14.000Z","date":"2026-01-05","kind":"purchase","planned":true,"acquired":true,"shares":775,"price":35.3926,"value":27429.265,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash."}],"balance_after":16847,"source":{"system":"sec-edgar","filing":"0001487937-26-000004","document":"wk-form4_1767811690.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000148793726000004/wk-form4_1767811690.xml","form_type":"4"}},{"id":944431,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":29981,"kind":"person","name":"Wheadon David E.","position":1,"cik":"0001789507","reported_name":"Wheadon David E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-07T18:47:00.000Z","date":"2026-01-05","kind":"purchase","planned":true,"acquired":true,"shares":1771,"price":35.3926,"value":62680.2946,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities acquired pursuant to the director's participation in a Non-Executive Director Purchase Plan to receive a portion of the fees received for service as a director in stock in lieu of cash."}],"balance_after":14395,"source":{"system":"sec-edgar","filing":"0001789507-26-000004","document":"wk-form4_1767811617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625297/000178950726000004/wk-form4_1767811617.xml","form_type":"4"}}]}